The forced social distancing mandated by the coronavirus may have provided the use case for technology-enabled advancement of clinical trial monitoring and other practices that could see widespread adoption after the pandemic – perhaps best exemplified by the study for the first vaccine authorized in the US.
Pfizer COVID Vaccine Trial Proved Remote Monitoring, Other Innovations Work, ICON CEO Says
Steve Cutler, head of the CRO that conducted Pfizer’s study, tells the Pink Sheet that starting clinical trials in weeks, as opposed to months, should be possible post-pandemic.
